Members directory | Become a member | My DCVMN

Contact us

News

January 19, 2025

Pharmacovigilance Working Group’s New Publication: Enhancing Vaccine Safety Surveillance in LMICs

DCVMN achievements DCVMN Working Groups Pharmacovigilance Publication

December 10, 2024

Pre-qualification of GreenSignal’s BCG vaccine

BCG developingcountries Prequalification Vaccines Vaccines & immunization WHO

October 13, 2024

DCVMN W𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲 C𝗮𝗽𝗮𝗰𝗶𝘁𝘆 B𝘂𝗶𝗹𝗱𝗶𝗻𝗴 Workshop in Dubai

WeConnectToProtect Workforce Training Workshop

September 23, 2024

Presenting DCVMN’s strategic focus for 2024-25 at the 2024 UNICEF Vaccine Industry Consultation

CEO DCVMN Advocacy UNICEF WeConnectToProtect

September 20, 2024

Exploring Key Strategies for Scaling Up MCM Manufacturing at the i-MCM-Net Partners Meeting

CEO DCVMN Advocacy developingcountries

August 15, 2024

Panacea Biotec and ICMR initiate Phase III Clinical Trial of DengiAll

clinicaltrials Dengue

August 1, 2024

DCVMN at the Global Pandemic Preparedness Summit 2024

CEO DCVMN Advocacy WeConnectToProtect

July 2, 2024

DCVMN CEO in the “2nd Edition of The Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa”

Africa DCVMN Advocacy Vaccines & immunization WeConnectToProtect

June 28, 2024

Regulatory Working Group Workshop on Next-Generation Sequencing (NGS) technology

DCVMN achievements DCVMN Working Groups Vaccines & immunization

June 25, 2024

DCVMN at the Global Forum for Vaccine Sovereignty and Innovation

CEO DCVMN Advocacy Vaccines & immunization

June 10, 2024

24th DCVMN Annual General Meeting Report

DCVMN achievements Publication

June 7, 2024

2023 DCVMN International Annual Report

DCVMN achievements WeConnectToProtect

Our sponsors

Our sponsors

Our sponsors

Our sponsors